Medical News

RSS

New AI tool detects early psychosis risk in youth speech

Nanyang Technological University, Singapore (NTU Singapore) and the Institute of Mental Health (IMH) have developed a novel artificial intelligence (AI) framework capable of identifying youths at high risk of psychosis - a severe mental health condition that typically emerges in adolescence to early adulthood where a person may experience hallucinations, delusions, and disordered thinking - from short samples of casual, spontaneous speech.

13 Oct 2026

Ensuring accessible work environments for disabled physicians may enhance patient care

New research indicates that 5% of practising physicians report a disability "always or often," and another 12% report disability "sometimes." The authors call for action on improving accessibility to ensure equity and sustainability in the physician workforce.

13 Oct 2026

Why managing vibration is critical in IVF

Explore how laboratory vibration can affect sensitive IVF procedures and how vibration surveys and passive isolation can help minimize disruption.

From TMC Vibration Control 13 Oct 2026

New research shows reduced toxicant exposure reduces biological activity

Two newly published studies from Imperial Brands scientists have provided further evidence that products associated with lower levels of combustion-related toxicants also produce substantially lower levels of combustion-related toxicants also produce substantially lower biological activity than cigarette smoke under laboratory conditions.

13 Oct 2026

CMAJ analysis urges Canada to pass Safe Social Media Act to protect children

Canada's proposed Safe Social Media Act, which aims to protect children, should be passed, according to an Analysis article in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.261104.

13 Oct 2026

Beyond ‘bad’ cholesterol: new clues to the risk of heart disease

Researchers at Chalmers University of Technology, in Sweden, shed new light on the remaining risk of heart disease, even after the known risk factor of ‘bad’ cholesterol is brought down to a healthy level.

13 Oct 2026

Bedfont® Scientific Ltd. acquires US-based company coVita™, marking the next chapter in its global growth

Bedfont®, a world leader in breath analysis, announces its acquisition of coVita™, building on 16 years of partnership, market knowledge, and established infrastructure to support global expansion.

From Bedfont® Scientific Ltd 13 Oct 2026

Undecimal Bio launches with $18 million oversubscribed seed financing to address ‘liver trap’ in siRNA therapeutic delivery

Undecimal Bio, a platform biotechnology company advancing targeted delivery of siRNA therapeutics, today announced an oversubscribed $18 million USD seed financing.

From UndecimalBio 13 Oct 2026

Mursla Bio publishes peer-reviewed validation of tissue-specific extracellular vesicle platform for liquid biopsy

Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of Extracellular Vesicles (impact factor 21.7), the founding journal of the International Society for Extracellular Vesicles. This validates the TS-EV platform for a new class of liquid biopsy: the multiomic disease biology of living cells in a chosen tissue, read from blood, starting with the liver.

From Mursla Bio 13 Oct 2026

Concept Life Sciences appoints Dr Adrijana Vinter as Chief Executive Officer

We are pleased to announce the appointment of Dr Adrijana Vinter as Chief Executive Officer. Dr Vinter brings more than 20 years of experience spanning medicinal chemistry research, commercial development and executive leadership in the pharmaceutical and contract research industry sectors.

From Concept Life Sciences 13 Oct 2026

Gene therapy and special goggles help some blind adults detect objects again

In a phase 1 study of 10 adults with advanced retinitis pigmentosa, researchers found that optogenetic gene therapy combined with light-stimulating goggles was generally well tolerated, although one participant experienced a severe but transient ocular adverse event. Seven participants showed improved light sensitivity, while four of eight who completed behavioral testing demonstrated modest gains in visual function, providing preliminary evidence of partial vision restoration that requires confirmation in larger controlled trials.

12 Oct 2026

Scientists pinpoint key hotspot driving tau propagation in dementia

Diseases such as Alzheimer's and frontotemporal dementia are considered neurodegenerative tauopathies, in which tau proteins in the brain misfold and lead to cognitive decline.

12 Oct 2026

Experts launch Europe-wide framework to guide AI use in mental health

The first Europe-wide expert working group on Artificial Intelligence in mental health launches today to the ECNP congress in Munich, where the group will host an open discussion, setting out the potential, the problems, and possible directions for AI in psychiatry and neuroscience.

12 Oct 2026

ADHD diagnoses rise as awareness improves across Europe, experts say

ADHD seems to be in the news everywhere, but is this due to a rise in cases or to changing awareness and diagnosis?

12 Oct 2026

Medical cannabis benefits for insomnia remain uncertain, Cochrane review finds

A new Cochrane review finds that existing evidence is too uncertain to determine whether medical cannabis improves sleep or daytime functioning in people with insomnia.

12 Oct 2026

Women with autoimmune diseases more likely to receive psychiatric misdiagnoses

Females with autoimmune diseases are significantly more likely than males to have their autoimmune disease misdiagnosed as a psychiatric or psychosomatic condition, according to a study of more than 6,600 patients.

12 Oct 2026

Long-term anabolic steroid use linked to lasting heart damage

Long-term use of anabolic-androgenic steroids (AAS) has serious consequences for the heart, according to a new study that has been following weightlifters for nearly 10 years.

12 Oct 2026

Year-long trial finds NAD-boosting supplement fails to improve early Parkinson's symptoms

In a phase 3 randomized clinical trial involving 410 people with early Parkinson disease, 52 weeks of nicotinamide riboside supplementation increased blood NAD levels but failed to improve clinical outcomes compared with placebo. Participants receiving the supplement had modestly worse overall disease scores, although the difference was below the threshold generally considered clinically meaningful.

12 Oct 2026

Your favorite song might make a needle prick hurt less

A study of 204 patients undergoing intravenous cannulation before MRI found that those listening to their favorite music reported significantly lower pain scores than patients hearing no music at 30 seconds and two minutes after puncture. Mozart was also associated with lower pain scores among patients with pre-existing pain, while relaxation music showed no significant benefit, although the non-randomized findings require confirmation.

12 Oct 2026

Study finds a surprising downside to having favourite foods

In a study of 279 adults, researchers found that initially reinforcing existing food preferences reduced learning flexibility when associations between foods and outcomes changed. Participants learned positive associations more readily than negative ones, while associations involving disliked foods were more adaptable than those involving liked foods.

12 Oct 2026